doi: 10.1016/j.bbapap.2005.08.017
LPS could activate airway epithelial cells, neutrophils, and alveolar macrophages, resulting in the release of numerous inflammatory mediators, such as reactive oxygen species (ROS), tumor necrosis factor- (TNF-), and interleukin-6 (IL-6)
Current evidence is promising, but additional clinical trials are necessary to establish: Long-term safety Optimal dosing Specific medical indications Standard treatment protocols Individuals interested in peptide therapy should seek professional medical evaluation before considering treatment
Do not go for a cheap deal - it's likely they're using unregulated products (fake Botox) and won't be sufficiently trained
What it does not do is settle how well BPC-157 works, or for whom
Look for these red flags: Cloudiness or Haziness: The solution should be perfectly clear, like pure water